avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tal1
|
ENSMUSG00000028717.6 | T cell acute lymphocytic leukemia 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Tal1 | mm10_v2_chr4_+_115059507_115059553 | 0.97 | 3.0e-22 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
29.6 | 88.9 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
14.9 | 119.0 | GO:0015671 | oxygen transport(GO:0015671) |
8.5 | 50.8 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
6.4 | 19.1 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
5.2 | 20.9 | GO:0045575 | basophil activation(GO:0045575) |
4.8 | 14.4 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
4.5 | 13.6 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
4.2 | 67.6 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
4.2 | 29.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
4.1 | 49.2 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
3.7 | 15.0 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
3.7 | 22.2 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
3.7 | 29.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
3.6 | 10.7 | GO:0033189 | response to vitamin A(GO:0033189) |
3.4 | 10.3 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) positive regulation of renin secretion into blood stream(GO:1900135) positive regulation of eosinophil activation(GO:1902568) |
3.3 | 19.9 | GO:0002317 | plasma cell differentiation(GO:0002317) |
3.3 | 33.1 | GO:0030916 | otic vesicle formation(GO:0030916) |
3.1 | 27.8 | GO:0032264 | IMP salvage(GO:0032264) |
2.9 | 65.9 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
2.5 | 7.5 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
2.5 | 19.8 | GO:0006735 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
2.1 | 58.3 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
2.1 | 16.6 | GO:0002326 | B cell lineage commitment(GO:0002326) |
1.9 | 5.6 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
1.8 | 5.5 | GO:0071661 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
1.8 | 32.2 | GO:0015816 | glycine transport(GO:0015816) |
1.8 | 40.6 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
1.6 | 23.8 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
1.4 | 14.1 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
1.4 | 7.0 | GO:0060244 | amygdala development(GO:0021764) negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
1.3 | 18.7 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
1.3 | 15.9 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
1.3 | 34.3 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
1.3 | 7.9 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.3 | 38.1 | GO:0051693 | actin filament capping(GO:0051693) |
1.3 | 5.2 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
1.0 | 62.6 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
1.0 | 36.9 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.9 | 5.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.9 | 18.9 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.7 | 2.1 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.7 | 22.7 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.7 | 15.7 | GO:0042730 | fibrinolysis(GO:0042730) |
0.6 | 5.5 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.6 | 2.4 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.6 | 4.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.6 | 4.1 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.6 | 14.6 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.5 | 10.4 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.5 | 3.1 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.5 | 12.4 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.5 | 1.5 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.4 | 4.9 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.4 | 4.5 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.4 | 18.1 | GO:0032094 | response to food(GO:0032094) |
0.4 | 8.8 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.4 | 4.7 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.4 | 7.3 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.4 | 2.9 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.4 | 27.4 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.4 | 4.2 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.4 | 24.3 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.3 | 5.2 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.3 | 4.8 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.3 | 5.8 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.3 | 2.9 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.3 | 6.5 | GO:0002467 | germinal center formation(GO:0002467) |
0.3 | 5.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 0.5 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.2 | 10.4 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 3.0 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.2 | 45.9 | GO:0007596 | blood coagulation(GO:0007596) |
0.2 | 8.9 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.2 | 11.5 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.2 | 11.4 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.2 | 1.5 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.2 | 12.0 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.2 | 2.6 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 1.6 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.2 | 1.2 | GO:0015840 | urea transport(GO:0015840) |
0.2 | 21.1 | GO:0030177 | positive regulation of Wnt signaling pathway(GO:0030177) |
0.2 | 3.2 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.2 | 7.3 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 19.1 | GO:0007586 | digestion(GO:0007586) |
0.1 | 4.4 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.1 | 17.9 | GO:0031497 | chromatin assembly(GO:0031497) |
0.1 | 3.1 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.1 | 6.0 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 8.5 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.1 | 2.6 | GO:0045109 | hair follicle morphogenesis(GO:0031069) intermediate filament organization(GO:0045109) |
0.1 | 3.5 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 1.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 1.3 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.1 | 0.5 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 6.3 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.0 | 0.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.8 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.0 | 7.8 | GO:0006935 | chemotaxis(GO:0006935) |
0.0 | 1.4 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.9 | 119.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
7.5 | 22.6 | GO:0034774 | secretory granule lumen(GO:0034774) cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
6.3 | 38.1 | GO:0032437 | cuticular plate(GO:0032437) |
5.8 | 58.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
3.7 | 15.0 | GO:0000802 | transverse filament(GO:0000802) |
2.9 | 31.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.9 | 13.6 | GO:0070187 | telosome(GO:0070187) |
1.7 | 29.9 | GO:0031143 | pseudopodium(GO:0031143) |
1.6 | 4.9 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
1.3 | 5.4 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
1.3 | 5.2 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
1.3 | 3.8 | GO:0005584 | collagen type I trimer(GO:0005584) |
1.1 | 15.9 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.8 | 3.2 | GO:0035841 | new growing cell tip(GO:0035841) |
0.8 | 3.1 | GO:0032280 | symmetric synapse(GO:0032280) |
0.7 | 10.0 | GO:0071437 | invadopodium(GO:0071437) |
0.7 | 2.1 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.7 | 15.3 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.6 | 4.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.6 | 11.5 | GO:0005861 | troponin complex(GO:0005861) |
0.6 | 6.3 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.5 | 16.5 | GO:0097228 | sperm principal piece(GO:0097228) |
0.4 | 7.6 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.4 | 16.6 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.4 | 4.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.4 | 62.7 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.4 | 5.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.3 | 18.9 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.3 | 1.4 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.3 | 10.1 | GO:0008305 | integrin complex(GO:0008305) |
0.2 | 40.9 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.2 | 2.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.2 | 71.0 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.2 | 3.9 | GO:0032982 | myosin filament(GO:0032982) |
0.2 | 11.0 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 33.1 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 12.8 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 3.0 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 3.7 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 11.7 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 2.9 | GO:0002102 | podosome(GO:0002102) |
0.1 | 112.9 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 43.0 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.1 | 3.7 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 32.1 | GO:0005768 | endosome(GO:0005768) |
0.1 | 4.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 8.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 2.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 64.7 | GO:0031410 | cytoplasmic vesicle(GO:0031410) |
0.0 | 4.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.2 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 7.9 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 2.6 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.1 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.9 | 119.0 | GO:0005344 | oxygen transporter activity(GO:0005344) |
7.4 | 22.2 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
7.1 | 49.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
4.9 | 24.3 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
4.5 | 13.6 | GO:1990955 | G-rich single-stranded DNA binding(GO:1990955) |
3.6 | 14.6 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
3.5 | 102.6 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
3.4 | 17.0 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
3.1 | 27.8 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
3.1 | 33.9 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
2.7 | 31.8 | GO:0038064 | collagen receptor activity(GO:0038064) |
2.6 | 10.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
2.6 | 10.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
2.4 | 67.6 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
2.4 | 14.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
2.3 | 32.2 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
2.2 | 19.8 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
2.1 | 6.4 | GO:0048030 | disaccharide binding(GO:0048030) |
2.1 | 16.6 | GO:0070644 | vitamin D response element binding(GO:0070644) |
2.0 | 10.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.9 | 5.6 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
1.3 | 7.9 | GO:0004359 | glutaminase activity(GO:0004359) |
1.3 | 162.4 | GO:0004540 | ribonuclease activity(GO:0004540) |
1.1 | 15.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
1.0 | 49.2 | GO:0050699 | WW domain binding(GO:0050699) |
1.0 | 7.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.9 | 7.3 | GO:0004064 | arylesterase activity(GO:0004064) |
0.9 | 5.2 | GO:1902282 | phosphorelay sensor kinase activity(GO:0000155) voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.8 | 7.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.7 | 10.4 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.7 | 52.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.7 | 12.8 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.6 | 4.5 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.6 | 3.0 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.6 | 9.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.5 | 4.8 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.5 | 30.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.5 | 3.2 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.4 | 2.6 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 13.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.4 | 5.4 | GO:0016918 | retinal binding(GO:0016918) |
0.4 | 1.5 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.4 | 5.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.4 | 72.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.3 | 12.4 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.3 | 2.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.3 | 9.3 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 5.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.3 | 2.4 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.3 | 3.8 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 13.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 28.3 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.2 | 36.1 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.2 | 17.7 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.2 | 6.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 22.0 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 3.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 2.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 17.3 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 3.5 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 4.7 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.1 | 1.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 10.7 | GO:0042562 | hormone binding(GO:0042562) |
0.1 | 12.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 6.3 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.5 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 41.2 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.1 | 10.1 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.1 | 35.4 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.5 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 5.7 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 11.2 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 5.4 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 3.5 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.0 | 14.2 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 1.4 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 22.3 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 3.6 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 2.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 30.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
1.1 | 37.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.8 | 32.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.6 | 27.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.4 | 16.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 40.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.4 | 10.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.4 | 97.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.4 | 13.2 | PID EPO PATHWAY | EPO signaling pathway |
0.4 | 10.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.3 | 4.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 18.9 | PID RHOA PATHWAY | RhoA signaling pathway |
0.3 | 7.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 5.6 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 19.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 6.4 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 4.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 3.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 4.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 2.9 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 3.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 5.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 2.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.7 | 55.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.7 | 55.8 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
1.5 | 27.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.3 | 37.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
1.1 | 44.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
1.0 | 24.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.8 | 27.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.8 | 33.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.6 | 6.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.6 | 18.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.6 | 10.1 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.5 | 4.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.5 | 4.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.5 | 10.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.5 | 22.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.4 | 16.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.4 | 7.5 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.4 | 7.9 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.4 | 19.8 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.3 | 2.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.3 | 37.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 5.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 15.0 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 9.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 25.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 27.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 5.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 2.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 2.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 2.7 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.5 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 2.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |